Catalyst Pharmaceuticals, Inc.

Catalyst is a specialty pharmaceutical company focused on in-licensing and developing. Read more

94 Followers on Owler
94 Followers on Owler
94 Followers on Owler
94 Followers on Owler

Catalyst Pharmaceuticals, Inc.

Catalyst is a specialty pharmaceutical company focused on in-licensing and developing. Read more

Patrick J. McEnany's photo - Chairman & CEO of Catalyst Pharmaceuticals, Inc.

Chairman & CEO

Patrick J. McEnany

CEO Approval Rating

91/100

Founded:

2002

Status:

PublicIndependent CompanyNASDAQCPRX

CATALYST PHARMACEUTICALS, INC. TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Acadia is Catalyst Pharmaceuticals, Inc.'s top competitor. Acadia was founded in 1993 in San Diego, California. Acadia competes in the Biotechnology field. Acadia generates $339.2M more revenue than Catalyst Pharmaceuticals, Inc..

Strongbridge Biopharma is perceived as one of Catalyst Pharmaceuticals, Inc.'s biggest rivals. Strongbridge Biopharma's headquarters is in Trevose, Pennsylvania, and was founded in 1996. Strongbridge Biopharma is in the Health Care Services industry. Strongbridge Biopharma generates 25% of Catalyst Pharmaceuticals, Inc.'s revenue.

Trusted Tablets is one of Catalyst Pharmaceuticals, Inc.'s top competitors. Trusted Tablets is a Private company that was founded in Larnaca, Larnarca District in 2007. Trusted Tablets operates in the Pharmaceuticals industry. Trusted Tablets has 273 more employees vs. Catalyst Pharmaceuticals, Inc..

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Voyager a competitor of Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$119.1M

Catalyst Pharmaceuticals, Inc.'s revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 207.7M. Over the last four quarters, Catalyst Pharmaceuticals, Inc.'s revenue has grown by 6.4%. Specifically, in Q4 2020's revenue was $31M; in Q3 2020, it was $29.3M; in Q2 2020, it was $29.6M; in Q1 2020, Catalyst Pharmaceuticals, Inc.'s revenue was $29.1M.

Catalyst Pharmaceuticals, Inc. Acquisitions

No recent acquisitions found related to Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. Funding History

Since Catalyst Pharmaceuticals, Inc. was founded in 2002, it has participated in 1 round of funding. In total Catalyst Pharmaceuticals, Inc. has raised $20.1M. Catalyst Pharmaceuticals, Inc.'s funding round was on Nov 2006 for a total of $20.1M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Nov 2006
$20.1M

Since Catalyst Pharmaceuticals, Inc. was founded in 2002, it has participated in 1 round of funding. In total Catalyst Pharmaceuticals, Inc. has raised $20.1M. Catalyst Pharmaceuticals, Inc.'s funding round was on Nov 2006 for a total of $20.1M

Catalyst Pharmaceuticals, Inc. Investments

No recent investments found related to Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. News

March 15, 2021BioSpace

Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

- Firdapse ® Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million - GAAP Net Inc... See more »
March 4, 2021BioSpace

Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 16th, 2021

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical compan... See more »
February 22, 2021Markets Insider

Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2021

Catalyst Supporting Facebook Live Panel on Living with a Rare Disease Hosted by The MightyCatalyst Ki... See more »
January 28, 2021Benzinga

Looking Into Catalyst Pharmaceuticals's Return On Capital Employed

Catalyst Pharmaceuticals (NASDAQ:CPRX) posted Q3 earnings of $11.70 million, an increase from Q2 of 1... See more »
January 6, 2021MarketScreener

Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update

(marketscreener.com) Company to Expand R&D Focus for Pipeline Growth to include Earlier Stage Program... See more »

Catalyst Pharmaceuticals, Inc. Blogs

May 31, 2016Catalyst Pharmaceuticals Blog

Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Wednesday, May 11th, 2016

CORAL GABLES, Fla., May 06, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a b... See more »
May 31, 2016Catalyst Pharmaceuticals Blog

Catalyst Pharmaceuticals Observes Rare Disease Day 2016

CORAL GABLES, Fla., Feb. 29, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a ... See more »
May 31, 2016Catalyst Pharmaceuticals Blog

Catalyst Pharmaceutical's Firdapse Phase 3 Study Published in Muscle & Nerve

CORAL GABLES, Fla., May 18, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a b... See more »
May 31, 2016Catalyst Pharmaceuticals Blog

Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference Call and Webcast on Wednesday, March 16th, 2016

CORAL GABLES, Fla., March 09, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a... See more »
May 31, 2016Catalyst Pharmaceuticals Blog

Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan

CORAL GABLES, Fla., May 17, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a b... See more »
May 31, 2016Catalyst Pharmaceuticals Blog

Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results

CORAL GABLES, Fla., March 15, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasd... See more »
May 31, 2016Catalyst Pharmaceuticals Blog

Catalyst Pharmaceuticals Provides Regulatory Update on Firdapse

CORAL GABLES, Fla., April 26, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a... See more »

Catalyst Pharmaceuticals, Inc. Press Releases

April 24, 2018EconoTimes

Catalyst Pharmaceuticals Introduces New Corporate Website

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on devel... See more »
February 13, 2018GlobeNewswire

Catalyst Biosciences Announces Pricing of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBI... See more »
October 16, 2017GlobalNewswire

Catalyst Pharmaceuticals to Present at 16th Annual BIO Investor Forum

CORAL GABLES, Fla., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasd... See more »
March 28, 2017Accesswire

Catalyst Pharmaceuticals and ZIOPHARM Oncology Bounce Up On FDA Phase News

NEW YORK, NY / ACCESSWIRE / March 28, 2017 / As FDA Phase trials continue, the two biopharmaceutical ... See more »
November 17, 2016NewsMaker

Lambert-Eaton Myasthenic Syndrome (LEMS) Pipeline: H2 2015 World Market Research Report

Lambert-Eaton Myasthenic Syndrome (LEMS) market report covers research informatics related to Lambert... See more »
October 3, 2016NewsMaker

Tourette Syndrome Pipeline H2 2016 Market Therapeutics Assessment Review

RnRMarketResearch.com adds 'Tourette Syndrome - Pipeline Review, H2 2016' Market Research to its data... See more »

Social Media

Catalyst Pharmaceuticals, Inc. Headquarters

355 Alhambra Circle Suite 1250

Coral Gables, Florida33134

305-420-3200

Driving Directions »

Trending Companies

Catalyst Pharmaceuticals, Inc. Summary

ABOUT

Overview

Catalyst is a specialty pharmaceutical company focused on in-licensing and developing. Catalyst Pharmaceuticals, Inc. was founded in 2002. Catalyst Pharmaceuticals, Inc.'s headquarters is located in Coral Gables, Florida, USA 33134. It has raised 20.1...

CEO

Catalyst Pharmaceuticals, Inc.'s Chairman & CEO, Patrick J. McEnany, currently has an approval rating of 91%. Catalyst Pharmaceuticals, Inc.'s primary competitors are Acadia, Strongbridge Biopharma & Trusted Tablets.

Website

catalystpharma.com

Frequently Asked Questions about Catalyst Pharmaceuticals, Inc.

  1. When was Catalyst Pharmaceuticals, Inc. founded?

    Catalyst Pharmaceuticals, Inc. was founded in 2002
  2. Who is Catalyst Pharmaceuticals, Inc.'s CEO?

    Catalyst Pharmaceuticals, Inc.'s CEO is Patrick J. McEnany
  3. How much revenue does Catalyst Pharmaceuticals, Inc. generate?

    Catalyst Pharmaceuticals, Inc. generates $119.1M in revenue
  4. How much funding does Catalyst Pharmaceuticals, Inc. have?

    Catalyst Pharmaceuticals, Inc. has historically raised $20.1M in funding
  1. Where is Catalyst Pharmaceuticals, Inc.'s headquarters?

    Catalyst Pharmaceuticals, Inc.'s headquarters is in Coral Gables Florida, USA
  2. How many employees does Catalyst Pharmaceuticals, Inc. have?

    Catalyst Pharmaceuticals, Inc. has 51 employees
  3. What sector does Catalyst Pharmaceuticals, Inc. operate in?

    Catalyst Pharmaceuticals, Inc. is in Biotechnology
  4. Who are Catalyst Pharmaceuticals, Inc.'s competitors?

    Catalyst Pharmaceuticals, Inc.'s top competitors are Acadia, Strongbridge Biopharma, Trusted Tablets